Tag Archives: ARWR

Tuesday’s Midday Movers: Arrowhead Research (ARWR), Clovis Oncology (CLVS), Ambarella (AMBA), Best Buy Co (BBY), Amarin (AMRN)

So far Tuesday, November 26, NASDAQ is down -0.46% and the S&P is up 0.6%. Here are this morning’s most active stocks: Arrowhead Research (ARWR – Research Report), Clovis Oncology (CLVS – Research Report), Ambarella (AMBA – Research Report), Best

Monday’s Midday Movers: Clovis Oncology (CLVS), Arrowhead Research (ARWR), Splunk (SPLK), Exact Sciences (EXAS), Zogenix (ZGNX)

So far Monday, November 25, NASDAQ is up 2.64% and the S&P is up 0.83%. Here are this morning’s most active stocks: Clovis Oncology (CLVS – Research Report), Arrowhead Research (ARWR – Research Report), Splunk (SPLK – Research Report), Exact

Cantor Fitzgerald Keeps a Hold Rating on Arrowhead Research (ARWR)

Cantor Fitzgerald analyst Elemer Piros maintained a Hold rating on Arrowhead Research (ARWR – Research Report) today and set a price target of $50.00. The company’s shares closed last Monday at $48.17, close to its 52-week high of $49.78. According

The CFO of Arrowhead Research is Exercising Options

Yesterday it was reported that the CFO of Arrowhead Research (ARWR – Research Report), Kenneth Allen Myszkowski, exercised options to buy 12,649 ARWR shares at $5.19 a share, for a total transaction value of $65.65K. Following Kenneth Allen Myszkowski’s last

Thursday’s Highlights at Noon: Arrowhead Research (ARWR), Kandi Technologies (KNDI), Sandstorm Gold (SAND), First Majestic Silver (AG)

So far Thursday, October 17, NASDAQ is down -1.12% and the S&P is down -0.36%. Here are this morning’s most active stocks: Arrowhead Research (ARWR – Research Report), Kandi Technologies (KNDI – Research Report), Sandstorm Gold (SAND – Research Report)

Monday’s Midday Movers: Agios Pharma (AGIO), Arrowhead Research (ARWR), Novavax (NVAX), Heron Therapeutics (HRTX), Pacira Pharmaceuticals (PCRX)

So far Monday, September 30, NASDAQ is up 2.04% and the S&P is up 1.39%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Agios Pharma (AGIO – Research Report), Arrowhead Research (ARWR –